Artificial Intelligence and Benign Lesions of Vocal Folds Recognition
Study Details
Study Description
Brief Summary
The development of Artificial Intelligence (AI), the evolution of voice technology, progresses in audio signal analysis, and natural language processing/understanding methods have opened the way to numerous potential applications of voice, such as the identification of vocal biomarkers for diagnosis, classification or to enhance clinical practice. More recently, researches focused on the role of the audio signal of the voice as a signature of the pathogenic process. Dysphonia indicates that some negative changes have occurred in the voice production. The overall prevalence of dysphonia is approximately 1% even if the actual rates may be higher depending on the population studied and the definition of the specific voice disorder. Voice health may be assessed by several acoustic parameters. The relationship between voice pathology and acoustic voice features has been clinically established and confirmed both quantitatively and subjectively by speech experts. The automatic systems are designed to determine whether the sample belongs to a healthy subject or a non-healthy subject. The exactness of acoustic parameters is linked to the features used to estimate them for speech noise identification. Current voice searches are mostly restricted to basic questions even if with broad perspectives. The literature on vocal biomarkers of specific vocal fold diseases is anecdotal and related to functional vocal fold disorders or rare movement disorders of the larynx . The most common causes of dysphonia are the Benign Lesions of the Vocal Fold (BLVF). Currently, videolaryngostroboscopy, although invasive, is the gold standard for the diagnosis of BLVF. However, it is invasive and expensive procedure. The novel ML algorithms have recently improved the classification accuracy of selected features in target variables when compared to more conventional procedures thanks to the ability to combine and analyze large data-sets of voice features. Even if the majority of studies focus on the diagnosis of a disorder where they differentiate between healthy and non-healthy subjects, the investigators believe that the more important task is frequently differential diagnosis between two or more diseases. Even though this is a challenging task, it is of crucial importance to move decision support to this level. The main aim of this research would be the study, development, and validation of ML algorithms to recognize the different BVLVFL from digital voice recordings.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The investigators will collect the audio recordings of dysphonic participants affected by BLVF. All voice samples will be divided into the following groups based on the endoscopic diagnosis: vocal fold cysts, Reinke's edema, nodules and polyps. The audio tracks will be obtained by asking to pronounce with usual voice intensity, pitch and quality the word /aiuole/ three times in a row. Voices will be acquired using a Shure model SM48 microphone (Evanston IL) positioned at an angle of 45° at a distance of 20 cm from the patient's mouth. The microphone saturation input will be fixed at 6/9 of CH1 and the environmental noise was <30 dB sound pressure level (SPL). The signals will be recorded in ".nvi" format with a high-definition audio-recorder Computerized Speech Lab, model 4300B, from Kay Elemetrics (Lincoln Park, NJ, USA) with a sampling rate of 50 kHz frequency and converted to ".wav" format. Each audio file will be anonymously labelled with gender and type of BLVF.
Analysis pipeline All the following analyses will be performed using MatLab R2019b, the MathWorks, Natick MA, USA. The analysis pipeline included signal pre-processing, features extraction, screening of the features, and model implementation.
Features extraction On the segmented signal, 66 different features in the time, frequency, and cepstral domain will be extracted. Then, seven statistical measures will be computed on the extracted features, namely: mean, standard deviation, skewness, kurtosis, 25th, 50th, and 75th percentiles. In addition, jitter, shimmer, and tilt of the power spectrum will be obtained from the whole unsegmented signal.
Features screening Features screening will be applied using biostatistical analyses on the whole dataset, to reduce the extended number of features to give as input to the classifier.
Two statistical tests will be used to screen relevant features for the classification task:
the one-way analysis of variance (ANOVA), when all the groups were normally distributed, and the Kruskal-Wallis test, otherwise. The groups' normality will be verified through the Kolmogorov-Smirnov test. For all the tests, a p-value <0.05 will be considered statistically significant.
- Model implementation A non-linear Support Vector Machine (SVM) with a Gaussian kernel is the algorithm chosen for this research. The classification performance will be measured through the accuracy and the average F1-score. Both metrics will be provided for the description of the overall classification performances and those obtained on gender sub-groups.
Study Design
Outcome Measures
Primary Outcome Measures
- validation of ML algorithms to recognize the different BVFL [five years]
The statistical measures computed on the extracted features are the following: mean, standard deviation, skewness, kurtosis, 25th, 50th, and 75th percentiles. In addition, jitter, shimmer, and tilt of the power spectrum will be obtained from the whole unsegmented signal.
Eligibility Criteria
Criteria
Inclusion criteria:
-
Reinke's edema
-
cyst of the vocal fold
-
nodule of the vocal fold
-
polyp of the vocal fold
Exclusion criteria:
-
previous laryngeal or thyroid surgery
-
previous speech therapy
-
current pulmonary diseases
-
current gastroesophageal reflux
-
laryngeal movement disorder or recurrent laryngeal nerve paralysis
-
Non-native Italian speakers
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Maria Raffaella Marchese | Roma | Italy | 00198 |
Sponsors and Collaborators
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 4519